Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), spécialiste international du diagnostic clinique, annonce que la Haute Cour a notifié à Novacyt que l'audience de l'affaire entre...
Le chiffre d'affaires et l'EBITDA sont conformes aux prévisions. Concentration sur la stratégie de croissance post-COVID-19 pour devenir un leader mondial du diagnostic clinique dans le domaine...
Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that Edwin Snape has informed the Board that he wishes to retire...
Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company’s genesig® COVID-19 3G Real-Time PCR test has been...
Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that David Allmond is stepping down as Chief Executive Officer (CEO...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.023 | -3.77049180328 | 0.61 | 0.625 | 0.584 | 348565 | 0.59749158 | DE |
4 | 0 | 0 | 0.587 | 0.739 | 0.542 | 514153 | 0.64417495 | DE |
12 | -0.223 | -27.5308641975 | 0.81 | 0.81 | 0.542 | 355782 | 0.64875409 | DE |
26 | 0.057 | 10.7547169811 | 0.53 | 1.59 | 0.515 | 777607 | 0.96016217 | DE |
52 | -0.133 | -18.4722222222 | 0.72 | 1.59 | 0.4932 | 500910 | 0.89541865 | DE |
156 | -3.743 | -86.4434180139 | 4.33 | 4.636 | 0.42 | 493515 | 1.29377757 | DE |
260 | 0.438 | 293.959731544 | 0.149 | 13.96 | 0.1438 | 1787156 | 3.14479849 | DE |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約